Psychometric properties of the itch numeric rating scale in patients with moderate to severe plaque psoriasis using data from a randomized clinical trial

被引：0
|
作者：
Naegli, April [1 ]
Zhu, Baojin [1 ]
Gaich, Carol [1 ]
Heredia, Emily [1 ]
Song, Grace [2 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Macrostat, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2014年 / 70卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P8729
引用
收藏
页码：AB181 / AB181
页数：1
相关论文
共 50 条
  • [31] Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies
    Gil Yosipovitch
    Adam Reich
    Martin Steinhoff
    Anke Beselin
    Toby Kent
    Martin Dossenbach
    Lovisa Berggren
    Carsten Henneges
    Thomas Luger
    Dermatology and Therapy, 2018, 8 : 621 - 637
  • [32] Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies
    Yosipovitch, Gil
    Reich, Adam
    Steinhoff, Martin
    Beselin, Anke
    Kent, Toby
    Dossenbach, Martin
    Berggren, Lovisa
    Henneges, Carsten
    Luger, Thomas
    DERMATOLOGY AND THERAPY, 2018, 8 (04) : 621 - 637
  • [33] Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis
    Yu, Ning
    Peng, Chen
    Zhou, Jing
    Gu, Jun
    Xu, Jinhua
    Li, Xia
    Bi, Xinling
    Deng, Hui
    Li, Xin
    Ding, Yangfeng
    Shi, Yuling
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : 437 - 446
  • [34] Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
    Gordon, Kenneth B.
    Langley, Richard G.
    Warren, Richard B.
    Okubo, Yukari
    Gold, Linda Stein
    Merola, Joseph F.
    Peterson, Luke
    Wixted, Krista
    Cross, Nancy
    Deherder, Delphine
    Thaci, Diamant
    JAMA DERMATOLOGY, 2022, 158 (07) : 735 - 744
  • [35] Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry
    Papp, Kim A.
    Gooderham, Melinda
    Lynde, Charles
    Brassard, Danielle
    Al-Mohammedi, Faisal
    Prajapati, Vimal H.
    Delorme, Isabelle
    Albrecht, Lorne
    Haydey, Richard
    Alam, Maryam Shayesteh
    Beecker, Jennifer
    Siddha, Sanjay
    Maguin, Marie
    Farag, Mahmoud S.
    Vieira, Antonio
    Rihakova, Lenka
    Langley, Richard G.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [36] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: Review of clinical data. Part II
    Papp, Kim A.
    Camisa, Charles
    Stone, Stephen P.
    Caro, Ivor
    Wang, Xiaolin
    Compton, Peter
    Walicke, Patricia A.
    Gottlieb, Alice B.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2005, 9 (06) : 313 - 323
  • [37] Clinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis:: results from a phase III international randomized, placebo-controlled trial
    Dubertret, L.
    Sterry, W.
    Bos, J. D.
    Chimenti, S.
    Shumack, S.
    Larsen, C. G.
    Shear, N. H.
    Papp, K. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) : 170 - 181
  • [38] Psychometric properties of the neck disability index and numeric pain rating scale in patients with mechanical neck pain
    Cleland, Joshua A.
    Childs, John A.
    Whitman, Julie M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (01): : 69 - 74
  • [39] Peak Pruritus Numerical Rating Scale response with abrocitinib in patients with moderate-to-severe atopic dermatitis: results from a randomized, phase III clinical trial
    Simpson, E. L.
    Staender, S.
    Yosipovitch, G.
    Kim, B.
    Cameron, M.
    DiBonaventura, M.
    Williams, D.
    Tatulych, S.
    Nduaka, C.
    Valdez, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E99 - E100
  • [40] Ixekizumab impact on itch severity compared to etanercept and placebo: Results from UNCOVER-2, a phase 3 trial in patients with moderate-to-severe plaque psoriasis
    Kimball, Alexa Boer
    Nikai, Enkeleida
    Zhu, Baojin
    Carlier, Hilde
    Yosipovitch, Gil
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S19 - S19
12345